-
1
To evaluate the efficacy of subconjunctival bevacizumab injection in vascular pterygium before surgical excision in preventing recurrence comparing with bare sclera technique
Published 2025-01-01Subjects: “…bevacizumab…”
Get full text
Article -
2
Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population
Published 2025-01-01Subjects: Get full text
Article -
3
-
4
Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy
Published 2025-01-01Subjects: “…atezolizumab‐bevacizumab…”
Get full text
Article -
5
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
Published 2025-01-01Subjects: Get full text
Article -
6
Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols
Published 2019-03-01Subjects: Get full text
Article -
7
Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
Published 2024-06-01Subjects: “…Intraoperative Intravitreal Bevacizumab…”
Get full text
Article -
8
Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
Published 2025-02-01Subjects: “…bevacizumab…”
Get full text
Article -
9
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study
Published 2025-02-01Subjects: “…bevacizumab…”
Get full text
Article -
10
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
11
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
Published 2025-01-01Subjects: Get full text
Article -
12
Efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients: a retrospective, comparative study
Published 2025-01-01Subjects: “…Bevacizumab plus chemotherapy…”
Get full text
Article -
13
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Subjects: Get full text
Article -
14
Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report
Published 2025-01-01Subjects: “…Atezolizumab plus bevacizumab…”
Get full text
Article -
15
Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
Published 2025-06-01Subjects: Get full text
Article -
16
IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
Published 2016-06-01Subjects: “…bevacizumab…”
Get full text
Article -
17
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy
Published 2025-01-01Subjects: Get full text
Article -
18
Prognostics optical coherence tomography biomarker in macular oedema secondary to retinal vein occlusion
Published 2025-01-01Subjects: Get full text
Article -
19
PHARMACOECONOMICAL RESEARCH OF THE USE OF SORAFENIB IN MALIGNANT TUMORS
Published 2016-09-01Subjects: Get full text
Article